Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Molecular Targeted Therapies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Not applicableLooking for participantsNCT06924463
What this trial is testing

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Who this might be right for
Rhabdomyosarcoma
Lille University 20
Not applicableStudy completedNCT02639871
What this trial is testing

Dynamic Neuroimaging Biomarkers in Huntington's Disease

Who this might be right for
Brain Neuroimaging Biomarkers in Huntington Disease
Assistance Publique - Hôpitaux de Paris 81
Not applicableLooking for participantsNCT07658833
What this trial is testing

TACE and/or HAIC Combined With Molecular-targeted Therapy and Immunotherapy for HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 120
Not applicableLooking for participantsNCT06218901
What this trial is testing

Association of Psychological Distress in Patients With Lung Cancer

Who this might be right for
Lung NeoplasmsPsychological DistressPrognosis Factors+3 more
Shanghai Chest Hospital 500
Not applicableNot Yet RecruitingNCT07327515
What this trial is testing

PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors

Who this might be right for
Malignant Tumors
Li Min 90
Testing effectiveness (Phase 2)Looking for participantsNCT07049055
What this trial is testing

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Engeneic Pty Limited 144
Testing effectiveness (Phase 2)Looking for participantsNCT04183712
What this trial is testing

Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA

Who this might be right for
Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine 102
Not applicableStudy completedNCT01118078
What this trial is testing

Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Wilms Tumor and Other Childhood Kidney TumorsRhabdoid Tumor of the Kidney+5 more
Children's Oncology Group 185
Not applicableUnknownNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188
What this trial is testing

Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

Who this might be right for
KRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more
Novartis Pharmaceuticals 344
Testing effectiveness (Phase 2)UnknownNCT04160416
What this trial is testing

MXELOXIRI Combined With Molecular Targeted Drug in mCRC

Who this might be right for
Unresectable Metastatic Colorectal Cancer
First Affiliated Hospital of Zhejiang University 48
Testing effectiveness (Phase 2)Looking for participantsNCT02029001
What this trial is testing

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Who this might be right for
Malignant Solid Neoplasms
Centre Leon Berard 900
Post-approval studies (Phase 4)UnknownNCT05187208
What this trial is testing

PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian CancerOvarian Cancer Stage III+1 more
Seoul National University Hospital 102
Not applicableUnknownNCT04331912
What this trial is testing

PFS and OS of Patients With Advanced Neuroendocrine Cancer (NEN) After Systemic Treatment

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 100
Not applicableLooking for participantsNCT06228599
What this trial is testing

Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence

Who this might be right for
Pancreas Cancer
Medical College of Wisconsin 40
Large-scale testing (Phase 3)Looking for participantsNCT05770102
What this trial is testing

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

Who this might be right for
MalignancyMalignant NeoplasmLymphoproliferative Disorders+7 more
Cancer Research UK 30
Not applicableStudy completedNCT05376644
What this trial is testing

Molecular Imaging of HER2 Expression in HER2-positive Breast Cancer Using 99mTc-ADAPT6 vs 99mTc-DARPinG3

Who this might be right for
Breast Cancer Female
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Not applicableLooking for participantsNCT07315542
What this trial is testing

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

Who this might be right for
ChondrosarcomasCartilage Tumours
St. Anne's University Hospital Brno, Czech Republic 300
Not applicableStudy completedNCT05412459
What this trial is testing

99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy

Who this might be right for
HER2-positive Breast CancerFemale
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Next Page